Abvc Biopharma (ABVC) Ending Cash Balance (2009 - 2026)
Abvc Biopharma's Ending Cash Balance was $11,294 in Q3 2026, down 98.7% from $853,911 a year earlier and down 64.6% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2025, Ending Cash Balance at Abvc Biopharma came in at $1.33 million, up 53.6% from FY2024.
- Ending Cash Balance shows a five-year compound annual growth rate of -23.3% (FY2020 to FY2025).
- In earlier years, Ending Cash Balance was $863,815 in FY2024 (+20.5%), $716,780 in FY2023 (-48.5%), $1.39 million in FY2022 (-78.8%) and $6.57 million in FY2021 (+31.3%).
- The Q3 2026 figure marks the lowest quarterly Ending Cash Balance since Q1 2018.
- Compared with a year earlier, Ending Cash Balance has declined for three straight quarters, with an average decline of 16.5% over the last eight quarters.
- The best year-over-year quarter for Ending Cash Balance over five years was Q2 2022 (growth of 117.2%); the worst was Q3 2026 (a decline of 98.7%).
- Per Business Quant data, ABVC's Ending Cash Balance in the three quarters before Q3 2026 was $31,944 (Q2 2026), $140,324 (Q1 2026) and $1.33 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | 11,294.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11,294.00 |
| Jun 30, 2026 | 31,944.00 |
| Mar 31, 2026 | 140,324.00 |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 853,911.00 |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 759,568.00 |
| Dec 31, 2024 | 863,815.00 |
| Sep 30, 2024 | 769,873.00 |
| Jun 30, 2024 | 742,769.00 |
| Mar 31, 2024 | 659,002.00 |
| Dec 31, 2023 | 716,780.00 |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 742,189.00 |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 1.39 Mn |
| Sep 30, 2022 | 1.97 Mn |
| Jun 30, 2022 | 3.60 Mn |
| Mar 31, 2022 | 3.43 Mn |
| Dec 31, 2021 | 6.57 Mn |
API Access
Abvc Biopharma Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();